Seòmar agus comataidhean

The Public Interest Conditions for this specific project are a matter for the UK Government.

Vaccines Taskforce, BEIS have provided the following commentary that the UK Government’s investments to fund Valneva’s early clinical trials and upgrade and expand Valneva’s Livingston manufacturing facility were made in line with HM Treasury’s Green Book.

Valneva is an important part of the life science eco-system and supports directly high value jobs directly.

Scottish Government can offer support to companies impacted by a change in projected work and if required, a package of mitigation measures can be delivered by Scottish Government and its agencies.

There is no indication Valneva is in this position, Valneva’s coronavirus vaccine candidate is just one range of speciality vaccines developed at the site to combat a number of infectious diseases.

UK Government Department of Business, Enterprise and Industrial Strategy (BEiS) commented that Valneva's manufacturing facility in Livingston is a unique facility that establishes permanent UK capability to manufacture inactivated viral vaccines – one of the most proven, widely used vaccine formats. It is one of few Biosafety Level 3 (BSL3) containment facilities in Europe and a key part of the UK’s long term pandemic preparedness as it will have the capability to grow rapidly new pandemic viruses which can be inactivated and combined with an adjuvant to create future vaccines. This capability could shorten the time dramatically to developing whole inactivated vaccines against future pandemic viruses.

Vaccines Taskforce and BEIS provided the following commentary that the UK Government has secured early access to 100 million doses of Valneva’s COVID-19 vaccine across 2021 and 2022.

The Prime Minister announced at the G7 on 11 June that the UK will donate 100 million surplus COVID-19 vaccine doses within the next year. The UK will donate 5 million doses by the end of September, beginning in the coming weeks, primarily for use in the world’s poorest countries. The Prime Minister has also committed to donating a further 95 million doses within the next year, including 25 million more by the end of 2021. 80% of the 100m doses will go to COVAX and the remainder will be shared bilaterally with countries in need. The vaccines will be drawn from across the UK’s supply of Oxford/AstraZeneca, Pfizer/BioNTech, Janssen, Moderna and others. Decisions on which vaccines will be shared will be based on the continued reliability of supply chains, regulatory restrictions and advice from the JCVI.

a) Valneva has not received economic development funding to expand their manufacturing capacity from the Scottish Government, but have received account management support and advice from Scottish Enterprise.

b) The UK Government through the Vaccines Taskforce and (BEiS) has supported Valneva by providing funding for its early clinical trials and has also made a multi-million-pound investment to upgrade and expand Valneva’s Livingston manufacturing facility, as part of its supply agreement for COVID-19 vaccines.

Due to the commercially confidential nature of supply agreements, the UK Government is not able to disclose any further details.

I am pleased to inform Parliament that Scotland’s Climate Assembly has today [23 June] laid its full report and recommendations in parliament.

I am grateful for the commitment shown by Assembly members, and to those that organised and contributed to this Assembly. It has been inspiring to see how the Assembly has come together during the pandemic and delivered its work entirely online.

In this year of COP26, Scotland’s Climate Assembly exemplifies how we are putting people at the heart of policy making, by consulting, engaging and involving citizens in decision-making. The Assembly’s ambitious recommendations provide support for the societal transformation we know will be needed for Scotland to become a net zero nation.

We welcome the recommendations made today by Scotland’s Climate Assembly. It is clear that Assembly members have taken great care to develop ambitious proposals, which are a credit to them and the dedication they have shown. We will take the necessary time to reflect on the recommendations and issue a comprehensive and cross-Government response in line with the requirements of the Climate Change (Scotland) Act.

The Scottish Government is committed to replacing the Princess Alexandra Eye Pavilion to ensure that future services are of a high quality and sustainable.

NHS Lothian submitted its review to the Scottish Government on 21 May 2021 and we have since accepted the review. The Scottish Government wrote to NHS Lothian on 9 June 2021 to invite it to submit an Outline Business Case (OBC) for the development of eye care services. This will be considered by Scottish Government’s NHS Capital Investment Group who will undertake a detailed review of the evidence provided.

Once an OBC is approved the next stage is submission of the Full Business Case (FBC) and construction normally begins shortly after approval of a FBC.

It is essential that the required due diligence is completed to ensure the best possible future services and facilities; and this will take time. We look forward to continuing to work with NHS Lothian to fully support them during this process.

We are putting in place a temporary arrangement to deal with such a scenario between 26 June and 11 July. In the event of extended play, and limited only to match days and the games where this occurs, closing time for hospitality premises showing the game will be extended up to 23:30 where required. This is not a blanket relaxation of the rules but a specific and pragmatic approach to facilitate safe viewing of full Euros matches. Guidance for the sector will be updated to reflect this temporary change.

The marriage notice (M10 form), or notice of intention to marry, is set out in a statutory instrument made by the Registrar General for Scotland, or their deputy, with the consent of the Scottish Ministers. Each party to the intended marriage can select in their marriage notice whether they should be designated in the marriage register as a bride or a bridegroom or they can choose for no designation to be entered.

The Registrar General and the Scottish Government will, when time permits, write to key stakeholders to seek their views on what changes may be required to the marriage notice.

Forestry and Land Scotland (FLS) and its predecessor Forest Enterprise Scotland (FES) has sold the following under the New Woodland Investment Programme (2021 - 2017) / Repositioning Programme (2007 – 2016). The figures in the following table include 6,598 hectares sold / transferred to communities and NGO’s under the National Forest Land Scheme and Community Asset Transfer Scheme:

Excluded are sales of ‘surplus’ assets, typically buildings and small parcels of land, sold under the Rationalisation policy.

The funds for disposals have been used for the following:

• Acquiring land for planting;
• Cost of woodland creation;
• Maintenance and management of new woodland creation;
• Starter Farms initiative;
• Transaction and programme costs both for acquisitions and disposals.

The New Woodland Investment programme was closed at the end of FY 20-21 and there will be no further land sales as part of the programme. Further acquisitions / residual obligations (to cover future costs as detailed above) remain to be discharged over the following four year period.

As announced as part of last year’s Capital Spending Review, FLS were allocated £30M of capital funding over the next five years (starting in FY 21-22) to purchase land for woodland creation and expansion of Scotland’s national forests and land.

The woodland sold by FLS / FES remains managed as woodland. Using the proceeds to subsequently purchase and plant additional land has ensured that the area of woodland in Scotland continues to increase.

I refer the member to the answer to question S6W-00570 on‎ 21 June 2021. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx.